XML 53 R41.htm IDEA: XBRL DOCUMENT v3.19.3
Fair Value of Financial Instruments (Tables)
9 Months Ended
Sep. 30, 2019
Fair Value Disclosures [Abstract]  
Schedule of estimated fair value of derivatives measured by level of fair value hierarchy
The Company’s financial assets and liabilities measured and reported at fair value on a recurring basis include the following as of:
September 30, 2019December 31, 2018
Level 1Level 2Level 3TotalLevel 1Level 2Level 3Total
Derivative assets(1)
$—  $655  $—  $655  $—  $16,687  $—  $16,687  
Derivative liabilities(2)
$—  $(2,741) $—  $(2,741) $—  $—  $—  $—  
Non-real estate investments(1)
$—  $5,545  $—  $5,545  $—  $2,713  $—  $2,713  
___________ 
1.Included in the prepaid expenses and other assets, net line item on the Consolidated Balance Sheets.
2.Included in the accounts payable, accrued liabilities and other line item on the Consolidated Balance Sheets.
Schedule of carrying value and fair value of notes payable
The table below represents the carrying value and fair value of the Company’s investment in securities and debt as of:
September 30, 2019December 31, 2018
Carrying Value
Fair Value
Carrying Value
Fair Value
Assets
U.S. Government securities$142,268  $147,355  $146,880  $147,686  
Liabilities
Unsecured debt(1)(2)
$2,381,581  $2,456,220  $2,274,352  $2,227,265  
Secured debt(1)
$364,960  $363,762  $365,381  $354,109  
In-substance defeased debt$135,846  $136,625  $138,223  $135,894  
Joint venture partner debt$66,136  $70,416  $66,136  $66,136  
_________________
1.Amounts represent debt excluding net deferred financing costs.
2.The registered senior notes were issued at a discount/premium resulting in a net premium, including amortization, of $1.6 million and a discount, including amortization, of $0.6 million at September 30, 2019 and December 31, 2018, respectively.